share_log

Illumina | 10-Q: Q2 2024 Earnings Report

Illumina | 10-Q: Q2 2024 Earnings Report

Illumina | 10-Q：2024财年二季报
美股SEC公告 ·  2024/08/08 05:32

Moomoo AI 已提取核心信息

Illumina reported Q2 2024 revenue of $1.11 billion, down 5% year-over-year, with Core Illumina revenue declining 6% to $1.09 billion. The company recorded significant goodwill and intangible impairment charges of $1.89 billion related to GRAIL, leading to a net loss of $1.99 billion. Gross margin improved to 64.8% from 62.2% in Q2 2023, driven by favorable sequencing consumables mix and operational efficiencies.On June 24, 2024, Illumina completed the spin-off of GRAIL, distributing 85.5% of GRAIL shares to stockholders while retaining a 14.5% stake. The company recorded a $328 million unrealized loss on its retained GRAIL investment. To fund the spin-off, Illumina borrowed $750 million through a new delayed draw credit facility at 6.7% interest rate due June 2025.The company ended Q2 with $994 million in cash and investments, including $444 million held overseas. Operating cash flow was $157 million for the first half of 2024. Illumina faces ongoing regulatory challenges, including a €432 million fine from the European Commission related to the GRAIL acquisition, which is being appealed.
Illumina reported Q2 2024 revenue of $1.11 billion, down 5% year-over-year, with Core Illumina revenue declining 6% to $1.09 billion. The company recorded significant goodwill and intangible impairment charges of $1.89 billion related to GRAIL, leading to a net loss of $1.99 billion. Gross margin improved to 64.8% from 62.2% in Q2 2023, driven by favorable sequencing consumables mix and operational efficiencies.On June 24, 2024, Illumina completed the spin-off of GRAIL, distributing 85.5% of GRAIL shares to stockholders while retaining a 14.5% stake. The company recorded a $328 million unrealized loss on its retained GRAIL investment. To fund the spin-off, Illumina borrowed $750 million through a new delayed draw credit facility at 6.7% interest rate due June 2025.The company ended Q2 with $994 million in cash and investments, including $444 million held overseas. Operating cash flow was $157 million for the first half of 2024. Illumina faces ongoing regulatory challenges, including a €432 million fine from the European Commission related to the GRAIL acquisition, which is being appealed.
Illumina报告2024年第二季度营业收入为11.1亿美金，同比下降5%，核心Illumina营业收入下降6%至10.9亿美金。公司因涉及GRAIL而计入了18.9亿美金的重大商誉和无形资产减值损失，导致净亏损达19.9亿美金。毛利率从2023年第二季度的62.2%提高至64.8%，得益于有利的测序耗材组合和运营效率。2024年6月24日，Illumina完成了GRAIL的分拆，将85.5%的GRAIL股份分配给股东，同时保留14.5%的股份。公司确认了32800万美金的未实现损失，涉及其持有的GRAIL投资。为了资助此次分拆，Illumina通过一个新的延期提款信用额度借款75000万美...展开全部
Illumina报告2024年第二季度营业收入为11.1亿美金，同比下降5%，核心Illumina营业收入下降6%至10.9亿美金。公司因涉及GRAIL而计入了18.9亿美金的重大商誉和无形资产减值损失，导致净亏损达19.9亿美金。毛利率从2023年第二季度的62.2%提高至64.8%，得益于有利的测序耗材组合和运营效率。2024年6月24日，Illumina完成了GRAIL的分拆，将85.5%的GRAIL股份分配给股东，同时保留14.5%的股份。公司确认了32800万美金的未实现损失，涉及其持有的GRAIL投资。为了资助此次分拆，Illumina通过一个新的延期提款信用额度借款75000万美金，利率为6.7%，到期日为2025年6月。公司在第二季度结束时拥有现金和投资99400万美金，其中包括境外持有的44400万美金。2024年上半年的经营现金流为15700万美金。Illumina面临持续的监管挑战，包括与GRAIL收购相关的43200万欧元罚款，正在上诉中。

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

独立文件7  查看翻译

独立文件8  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    燃石医学
    BNR
    -- 6.940
    Neuronetics
    STIM
    -- 4.360
    Personalis
    PSNL
    -- 5.510
    OncoCyte
    OCX
    -- 2.5600
    恩佐生化
    ENZ
    -- 0.545
    解锁完整榜单
    热门讨论
    特朗普2.0时代开启，全球市场会如何演变？
    🎙️讨论： 1. 关税政策将如何影响美股、黄金、比特币等核心资产的走势？ 2. 在此背景下，有哪些投资机会值得关注？你会如何布局？ 展开
    MicroStrategy 2024年第四季度业绩电话会
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。